-
Collecting Patient Preference Information (PPI) in In-Trial/Exit Interviews: Current Perspectives and Future Considerations
Sep 9, 2025, 16:22 PM -
Health State Utilities Associated With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Sep 9, 2025, 16:22 PM -
A Retrospective Analysis of Reimbursement Timelines in Ireland: What Does a 10-Year Analysis Show?
Sep 9, 2025, 16:22 PM -
Clinical Humanistic and Economic Burden Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Fragmentation in Access Pathways: A Review of HTA and Decision-Making Processes for Medicines in Finland
Sep 9, 2025, 16:22 PM -
Exploring the Economic Burden Associated With Chronic Obstructive Pulmonary Disease (COPD) Due to Alpha1 Antitrypsin Deficiency (AATD): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
When Trials Don’t Meet: A Retrospective Statistical Analysis Using Matching-Adjusted Indirect Comparison (MAIC) and Individual Patient Data (IPD) to Compare Catiolanze® With Other Preservative-Free (PF) Latanoprost in Open-Angle Glaucoma (OAG)
Sep 9, 2025, 16:22 PM -
Accumulating Evidence: When Publication Bias Persists
Sep 9, 2025, 16:22 PM -
The Socioeconomic Value of Adult Respiratory Immunization Programs in France: Can Improved Coverage Unlock Missed Gains?
Sep 9, 2025, 16:22 PM -
Turning SAP Feedback into HTA-Ready Action: A Semi-Automated Approach for RWD Studies
Sep 9, 2025, 16:22 PM -
From Diagnosis to Treatment: Evaluating Timeliness and Treatment Patterns in Czech Pancreatic Cancer Patients
Sep 9, 2025, 16:22 PM -
Current Methodological Practices to Define Within-Patient Meaningful Change in Rare Diseases: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Patient Preferences for Type 2 Diabetes Mellitus (T2DM) Treatment: A Systematic Review of Discrete Choice Experiments Studies
Sep 9, 2025, 16:22 PM -
Cardiovascular Event Rates and Mortality Among Secondary-Prevention Hypercholesterolemia Patients in Japan
Sep 9, 2025, 16:22 PM -
Predicting Self-Efficacy in Managing Type 2 Diabetes: Results From a Low-Income, Less Educated Community of Quetta City, Pakistan
Sep 9, 2025, 16:22 PM -
Dutch Cost Implications of Faricimab in Neovascular Age-Related Macular Degeneration: A Systematic Review of Treatment Interval and Injection Frequency
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Add-On Vericiguat to Standard Treatment in Thai Patients With Heart Failure and Reduced Ejection Fraction
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis of Survival Outcomes in the First-Line Treatment of Unresectable or Metastatic Melanoma: Scoping Review of Methodology
Sep 9, 2025, 16:22 PM -
The Phantom Menace: How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access
Sep 9, 2025, 16:22 PM -
The Innovative Licensing and Access Pathway (ILAP): Early Pathway Experience, Examining, Process Adaptations, and Industry Impact
Sep 9, 2025, 16:22 PM
